Radiomics: a new tool to differentiate adrenocortical adenoma from carcinoma | Zendy

Francesca Torresan | Zendy; Filippo Crimì | Zendy; Filippo Ceccato | Zendy; Francesca Zavan | Zendy; Mattia Barbot | Zendy; Carmelo Lacognata | Zendy; Raffaella Motta | Zendy; Claudia Armellin | Zendy; Carla Scaroni | Zendy; Emilio Quaia | Zendy; Cristina Campi | Zendy; Maurizio Iacobone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Radiomics: a new tool to differentiate adrenocortical adenoma from carcinoma

Author(s) -

Francesca Torresan,

Filippo Crimì,

Filippo Ceccato,

Francesca Zavan,

Mattia Barbot,

Carmelo Lacognata,

Raffaella Motta,

Claudia Armellin,

Carla Scaroni,

Emilio Quaia,

Cristina Campi,

Maurizio Iacobone

Publication year - 2021

Publication title -

bjs open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.974

H-Index - 9

ISSN - 2474-9842

DOI - 10.1093/bjsopen/zraa061

Subject(s) - adrenocortical carcinoma , medicine , adrenocortical adenoma , malignancy , adenoma , radiology , carcinoma , pathology

The main challenge in the management of indeterminate incidentally discovered adrenal tumours is to differentiate benign from malignant lesions. In the absence of clear signs of invasion or metastases, imaging techniques do not always precisely define the nature of the mass. The present pilot study aimed to determine whether radiomics may predict malignancy in adrenocortical tumours.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research